Daniel Stauder
Stock Analyst at Citizens JMP
(4.15)
# 1,609
Out of 5,189 analysts
51
Total ratings
48.9%
Success rate
16.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBOT Microbot Medical | Reiterated: Buy | $2.5 → $2 | $0.68 | +194.12% | 2 | Nov 17, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $144 | $120.16 | +19.84% | 1 | Nov 16, 2026 | |
| AORT Artivion | Reiterated: Buy | $48 → $42 | $18.16 | +131.28% | 11 | Nov 6, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Buy | $127 → $110 | $73.61 | +49.44% | 12 | Nov 5, 2026 | |
| IART Integra LifeSciences Holdings | Reiterated: Buy | $22 | $13.25 | +66.04% | 1 | Oct 22, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $52 → $68 | $55.39 | +22.77% | 16 | Oct 21, 2026 | |
| STXS Stereotaxis | Reiterated: Buy | $4 → $3 | $0.9422 | +218.40% | 2 | Aug 27, 2026 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $1.25 | n/a | 6 | Mar 5, 2025 |
Microbot Medical
Nov 17, 2026
Reiterated: Buy
Price Target: $2.5 → $2
Current: $0.68
Upside: +194.12%
Haemonetics
Nov 16, 2026
Reiterated: Buy
Price Target: $144
Current: $120.16
Upside: +19.84%
Artivion
Nov 6, 2026
Reiterated: Buy
Price Target: $48 → $42
Current: $18.16
Upside: +131.28%
LeMaitre Vascular
Nov 5, 2026
Reiterated: Buy
Price Target: $127 → $110
Current: $73.61
Upside: +49.44%
Integra LifeSciences Holdings
Oct 22, 2026
Reiterated: Buy
Price Target: $22
Current: $13.25
Upside: +66.04%
AtriCure
Oct 21, 2026
Reiterated: Buy
Price Target: $52 → $68
Current: $55.39
Upside: +22.77%
Stereotaxis
Aug 27, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $0.9422
Upside: +218.40%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $1.25
Upside: n/a